224 results on '"Idée, Jean-Marc"'
Search Results
2. Safety and Gadolinium Distribution of the New High-Relaxivity Gadolinium Chelate Gadopiclenol in a Rat Model of Severe Renal Failure
3. Physicochemical and Pharmacokinetic Profiles of Gadopiclenol: A New Macrocyclic Gadolinium Chelate With High T1 Relaxivity
4. Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats
5. Multimodal Imaging Study of Gadolinium Presence in Rat Cerebellum: Differences Between Gd Chelates, Presence in the Virchow-Robin Space, Association With Lipofuscin, and Hypotheses About Distribution Pathway
6. Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue: Critical Appraisal and Suggestions for Harmonization—A Joint Initiative
7. Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: Role of pharmaceutical formulation
8. Safety profiles of gadolinium chelates in juvenile rats differ according to the risk of dissociation
9. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: A review
10. Iodinated Contrast Media: from Non-Specific to Blood-Pool Agents
11. Small Brain Lesion Enhancement and Gadolinium Deposition in the Rat Brain
12. Involvement of Gadolinium Chelates in the Mechanism of Nephrogenic Systemic Fibrosis: An Update
13. Barium Interactions
14. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review
15. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals
16. Nephrogenic Systemic Fibrosis-Like Effects of Magnetic Resonance Imaging Contrast Agents in Rats with Adenine-Induced Renal Failure
17. Retention of Gadolinium in Brain Parenchyma: Pathways for Speciation, Access, and Distribution. A Critical Review.
18. P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results
19. Recent advances in iron oxide nanocrystal technology for medical imaging
20. Superparamagnetic Contrast Agents
21. Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation
22. Role of thermodynamic and kinetic parameters in gadolinium chelate stability
23. Anaphylactic shock after first exposure to a macrocyclic gadolinium chelate: A few comments
24. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review
25. Letter to the Editor
26. Comment on “In VivoDrug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma”
27. One-year Retention of Gadolinium in the Brain: Comparison of Gadodiamide and Gadoterate Meglumine in a Rodent Model
28. Region of Interest Selection in Nonclinical Studies of Accumulated Gadolinium-based Contrast Agent–induced T1 Hyperintensity in Deep Cerebellar Nuclei
29. Comment on “In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma”
30. Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents
31. Erratum to: The role of phosphate on Omniscan® dechelation: an in vitro relaxivity study at pH 7
32. The role of phosphate on Omniscan® dechelation: an in vitro relaxivity study at pH 7
33. Erratum to a comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging
34. Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats
35. A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging
36. Transcatheter embolization therapy in liver cancer: an update of clinical evidences
37. Theranostics and contrast-agents for medical imaging: a pharmaceutical company viewpoint
38. Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
39. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats
40. Scientific and industrial challenges of developing nanoparticle-based theranostics and multiple-modality contrast agents for clinical application
41. Analytical Interference in Serum Iron Determination Reveals Iron Versus Gadolinium Transmetallation With Linear Gadolinium-Based Contrast Agents
42. The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update
43. Safety profiles of gadolinium-based contrast agents in pre-weaning juvenile rats differ according to the risk of gadolinium release
44. Barium Interactions
45. Nephrogenic Systemic Fibrosis-Like Effects of Magnetic Resonance Imaging Contrast Agents in Rats with Adenine-Induced Renal Failure
46. Skin Gadolinium Following Use of MR Contrast Agents in a Rat Model of Nephrogenic Systemic Fibrosis
47. Letters from Our Members.
48. Gadolinium Contrast Agent Associated Stimulation of Human Fibroblast Collagen Production
49. Comparative In Vivo Dissociation of Gadolinium Chelates in Renally Impaired Rats
50. Clinical, Biological, and Skin Histopathologic Effects of Ionic Macrocyclic and Nonionic Linear Gadolinium Chelates in a Rat Model of Nephrogenic Systemic Fibrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.